2025 annual financial data

Immuneering 2025 Operating margin

Immuneering 2025 operating margin with verified reported values.

Direct answer

Operating margin was Not calculable.

Operating income was -59,375,969 USD and net income was -56,024,898 USD.
Operating cash flow was -45,344,595 USD.

Get free Immuneering email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-59,375,969 USD
Net income
-56,024,898 USD
Operating cash flow
-45,344,595 USD